Sanofi makes changes to Executive Committee Sanofi makes changes to Executive Committee Supporting the French pharmaceutical firm's 2020 Strategic Roadmap Faron strengthens executive team by appointing new Medical Director Faron strengthens executive team by appointing new Medical Director He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer He has spent more than 30 years practising medicine and leading oncology drug development projects at pharma firms Key management changes aim to support future growth at Scancell Key management changes aim to support future growth at Scancell The firm also opens new US headquarters in San Diego Astellas names Rodrigo Fernandez as Executive Director, International Business Astellas names Rodrigo Fernandez as Executive Director, International Business Fernandez to lead Astellas' business in Latin America outside Brazil Sciformix names Fran Bates as VP of Technology Services Sciformix names Fran Bates as VP of Technology Services Appointment supports customer needs and future growth by offering technology services solutions focused on science Chief Commercial Officer appointed at Biohaven Chief Commercial Officer appointed at Biohaven John Tilton takes the newly created position at the US biopharmaceutical firm Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer The company has a unique approach to the development of novel immuno-oncology candidates Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Desai has more than 20 years of experience in the oncology field New Chief Scientific Officer for AnaptysBio New Chief Scientific Officer for AnaptysBio Dr Matthew Moyle will be responsible for the discovery and early development of therapeutic antibodies generated using AnaptysBio's SHM-XEL platform Louis Yu joins AMRI as Senior Vice President, Quality and Compliance Louis Yu joins AMRI as Senior Vice President, Quality and Compliance He will oversee all aspects of quality and cGMP compliance across all divisions of AMRI AMO Pharma makes three new appointments AMO Pharma makes three new appointments All have widespread experience in the pharmaceutical industry Lumos Pharma appoints David Weiner as Chief Medical Officer Lumos Pharma appoints David Weiner as Chief Medical Officer He will steer the development of the company's rare and orphan disease therapeutics PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager Joins the firm's international sales team Sandford Sommer joins Vernalis as President & Chief Operating Officer Sandford Sommer joins Vernalis as President & Chief Operating Officer Prior to joining the UK firm Sommer spent 24 years at AstraZeneca Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer He will be responsible for the clinical strategy and development of Cristal Therapeutics’ nanomedicines